Ownership history in Qube Research & Technologies Ltd · 9 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in IMMUNIC INC (IMUX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 32,669 | -2,320 | -6.6% | 0.00% | $29K | $0.88 |
| 2025 Q1 | REDUCED | 34,989 | -130,772 | -78.9% | 0.00% | $38K | $1.09 |
| 2024 Q4 | REDUCED | 165,761 | -9,200 | -5.3% | 0.00% | $166K | $1.00 |
| 2024 Q3 | ADDED | 174,961 | +174,910 | +342960.8% | 0.00% | $289K | $1.65 |
| 2024 Q2 | REDUCED | 51 | -7 | -12.1% | 0.00% | $56 | $1.11 |
| 2023 Q4 | UNCHANGED | 58 | — | 0% | 0.00% | $87 | $1.50 |
| 2023 Q3 | REDUCED | 58 | -14,284 | -99.6% | 0.00% | $85 | $1.47 |
| 2022 Q3 | REDUCED | 14,342 | -1,368 | -8.7% | 0.00% | $45K | $3.16 |
| 2022 Q2 | INITIATED | 15,710 | — | — | 0.00% | $55K | $3.47 |
As of 2025 Q4 — sorted by position size